Welcoming a global collaboration focus on developing solutions to AMR

We welcome a global collaborative focus on developing solutions to the issue of antimicrobial resistance (AMR). We believe people around the world deserve to be protected against life-threatening and quality-of-life degrading sicknesses as far as possible. As a large and prominent global manufacturer of medicines and health solutions, we commit to playing a role and through collaboration with industry peers and global health organizations to identify solutions to protect populations and provide new ways to reduce AMR.
Welcoming a global collaboration focus on developing solutions to AMR

The issue in a nutshell

Globally, bacterial resistance to antibiotics has been increasing dramatically. Combating this growth is a top priority for global public health. There is a particular concern that antibiotics are losing effectiveness faster than they are being replaced by new, innovative drugs, including antibiotics and alternative non-antibiotic approaches to treating and preventing infections. Currently it is estimated that more than 700,000 people die every year as a result of antibiotic resistance. By 2050, this is expected to rise to 10 millideaths annually if this disturbing trend is not curbed.

What’s been done so far


Following discussions at the World Economic forum in Davos, Switzerland in 2016, the global pharmaceutical industry came together to commit to collective action to:

  1. Commit government funding and support around the world to enhance the conservation of new and existing antibiotics, and measures to prevent overprescribing of antibiotics.
  2. Improve integration of real-time diagnostics with antibiotics to ensure appropriate use of antibiotics for the patients who need them.
  3. Advance stewardship, conservation, hygiene, and new commercial models for antibiotics and diagnostics to combat resistant infections.

To date, 98 companies and 11 industry associations in 21 countries have signed this declaration. Teva Pharmaceuticals is proud to be among them. For more information, see ifpma.org.

What we commit to:

As a partner to the industry, health associations and regulators in finding solutions to AMR, we commit to:

  • Antibiotics only being used in patients who need them, we support continued education for clinical professionals on appropriate use, and we welcome the WHO Global Action Plan’s focus on improved stewardship.
  •  We encourage infection control via improved hygiene, vaccination, and preventive treatments to help reduce the number of infections needing antibiotic treatment.
  • We support measures to reduce environmental impact from antibiotics, along with a ‘one health’ approach towards prudent and responsible use, including a global reduction of unnecessary antibiotic use in livestock, and
  • As acknowledged, the value assigned to antibiotics and diagnostics often does not reflect the investment required for their creation or the benefits they bring to society, and we stand ready to work with payers and policymakers on new valuation mechanisms and commercial models that specifically address the unique challenges of this market.
  • We support new ways of working such as open collaborations between industry and public researchers to overcome the scientific challenges of creating new antibiotics and diagnostics. Collaborative public-private projects already demonstrate what we can achieve together, but more can be done.
  • As part of the WHO Global Action Plan’s proposal for a comprehensive program of sanitation, hygiene, vaccination, infection control, education, and stewardship, we support mechanisms to ensure affordable access to new and existing antibiotics to the patients who need them, in all parts of the world and at all levels of income.
  • We recognize the success of programs to improve global access to drugs in HIV, TB, and malaria and call for a similar collaborative effort to address issues of access to antibiotics

Through these actions, we aim to be active partners in the fight against AMR and to enable millions of people live healthier, better days.